IL1B and COVID-19: The binding of COVID-19 to the Toll-like receptor (TLR) led to the release of pre-IL-1β, which was cleaved by caspase-1, followed by the activation of the inflammasome and the production of active mature IL-1β, which is a mediator of lung inflammation (62).